KALVISTA PHARMACEUTICALS |
USA |
Gesundheit |
US4834971032 / A2DG49 |
4XC1 (Frankfurt) / KALV (NASDAQ) |
FRA:4XC1, ETR:4XC1, 4XC1:GR, NASDAQ:KALV |
- |
https://www.kalvista.com/ |
KalVista Pharmaceuticals Inc. is a clinical-stage ..
>Volltext.. |
535.33 Mio. EUR |
489.07 Mio. EUR |
1.22 Mio. EUR |
-172.45 Mio. EUR |
-173.55 Mio. EUR |
-3.42 EUR |
118.31 Mio. EUR |
106.22 Mio. EUR |
-142.86 Mio. EUR |
4.99 |
- |
-35.86% |
- |
- |
- |
KALVISTA |
28.09.25 |
|
||||
|